342
Views
11
CrossRef citations to date
0
Altmetric
Review

Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport

ORCID Icon, , &
Pages 795-804 | Received 10 Apr 2017, Accepted 04 Jul 2017, Published online: 12 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melissa Pergakis, Neeraj Badjatia & J. Marc Simard. (2021) An update on the pharmacological management and prevention of cerebral edema: current therapeutic strategies. Expert Opinion on Pharmacotherapy 22:8, pages 1025-1037.
Read now

Articles from other publishers (10)

Erin McMoneagle, Jin Zhou, Shiyao Zhang, Weixue Huang, Sunday Solomon Josiah, Ke Ding, Yun Wang & Jinwei Zhang. (2023) Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment. Acta Pharmacologica Sinica.
Crossref
Chih-Hao Shen, Jr-Yu Lin, Cheng-Yo Lu, Sung-Sen Yang, Chung-Kan Peng & Kun-Lun Huang. (2021) SPAK-p38 MAPK signal pathway modulates claudin-18 and barrier function of alveolar epithelium after hyperoxic exposure. BMC Pulmonary Medicine 21:1.
Crossref
Shinya Fujii, Eriko Kikuchi, Honoka Suzuyama, Yuko Watanabe, Mari Ishigami‐Yuasa, Hiroyuki Masuno, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida & Hiroyuki Kagechika. (2021) Structural Development of Salicylanilide‐Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem 16:18, pages 2817-2822.
Crossref
Yating Gong, Muyao Wu, Fan Gao, Mengying Shi, Haiping Gu, Rong Gao, Bao-Qi Dang & Gang Chen. (2021) Inhibition of the p‑SPAK/p‑NKCC1 signaling pathway protects the blood‑brain barrier and reduces neuronal apoptosis in a rat model of surgical brain injury. Molecular Medicine Reports 24:4.
Crossref
Yucan Chen, Min Liu, Weidi Wang, Wenxiang Cai, WeiChen Song, Li Li & Guan Ning Lin. (2021) Loss of Setd2 associates with aberrant microRNA expression and contributes to inflammatory bowel disease progression in mice. Genomics 113:4, pages 2441-2454.
Crossref
Nur Farah Meor Azlan & Jinwei Zhang. (2020) Role of the Cation-Chloride-Cotransporters in Cardiovascular Disease. Cells 9:10, pages 2293.
Crossref
Shinya Fujii, Eriko Kikuchi, Yuko Watanabe, Honoka Suzuyama, Mari Ishigami-Yuasa, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida & Hiroyuki Kagechika. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling. Bioorganic & Medicinal Chemistry Letters 30:17, pages 127408.
Crossref
Jinwei Zhang, Mohammad Iqbal H. Bhuiyan, Ting Zhang, Jason K. Karimy, Zhijuan Wu, Victoria M. Fiesler, Jingfang Zhang, Huachen Huang, Md Nabiul Hasan, Anna E. Skrzypiec, Mariusz Mucha, Daniel Duran, Wei Huang, Robert Pawlak, Lesley M. Foley, T. Kevin Hitchens, Margaret B. Minnigh, Samuel M. Poloyac, Seth L. Alper, Bradley J. Molyneaux, Andrew J. Trevelyan, Kristopher T. Kahle, Dandan Sun & Xianming Deng. (2020) Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a. Nature Communications 11:1.
Crossref
Quentin Chevy, Clémence Simonnet, Sana Al Awabdh, Sabine Lévi & Jean Christophe Poncer. 2020. Neuronal Chloride Transporters in Health and Disease. Neuronal Chloride Transporters in Health and Disease 133 158 .
Jeannine M. C. Gregoriades, Aaron Madaris, Francisco J. Alvarez & Francisco J. Alvarez-Leefmans. (2019) Genetic and pharmacological inactivation of apical Na + -K + -2Cl − cotransporter 1 in choroid plexus epithelial cells reveals the physiological function of the cotransporter . American Journal of Physiology-Cell Physiology 316:4, pages C525-C544.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.